Annual Debt To Equity
-0.26
+1.10+80.88%
December 31, 2023
Summary
- As of February 8, 2025, BCLI annual debt to equity ratio is -0.26, with the most recent change of +1.10 (+80.88%) on December 31, 2023.
- During the last 3 years, BCLI annual debt to equity has fallen by -0.46 (-230.00%).
- BCLI annual debt to equity is now -125.24% below its all-time high of 1.03, reached on March 31, 2003.
Performance
BCLI Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
-0.14
+0.13+48.15%
September 30, 2024
Summary
- As of February 8, 2025, BCLI quarterly debt to equity ratio is -0.14, with the most recent change of +0.13 (+48.15%) on September 30, 2024.
- Over the past year, BCLI quarterly debt to equity has increased by +0.13 (+48.15%).
- BCLI quarterly debt to equity is now -100.27% below its all-time high of 51.67, reached on December 31, 2003.
Performance
BCLI Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
BCLI Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +80.9% | +48.1% |
| 3 y3 years | -230.0% | +48.1% |
| 5 y5 years | -100.0% | +48.1% |
BCLI Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -200.0% | +80.9% | -104.4% | +89.7% |
| 5 y | 5-year | -200.0% | +80.9% | -104.4% | +89.7% |
| alltime | all time | -125.2% | +80.9% | -100.3% | +89.7% |
Brainstorm Cell Therapeutics Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -0.14(-48.1%) |
| Jun 2024 | - | -0.27(+35.0%) |
| Mar 2024 | - | -0.20(-23.1%) |
| Dec 2023 | -0.26(-80.9%) | -0.26(-76.8%) |
| Sep 2023 | - | -1.12(+31.8%) |
| Jun 2023 | - | -0.85(+11.8%) |
| Mar 2023 | - | -0.76(-44.1%) |
| Dec 2022 | -1.36(-623.1%) | -1.36(-143.2%) |
| Sep 2022 | - | 3.15(+425.0%) |
| Jun 2022 | - | 0.60(+57.9%) |
| Mar 2022 | - | 0.38(+46.2%) |
| Dec 2021 | 0.26(+30.0%) | 0.26(+18.2%) |
| Sep 2021 | - | 0.22(+10.0%) |
| Jun 2021 | - | 0.20(+11.1%) |
| Mar 2021 | - | 0.18(-10.0%) |
| Dec 2020 | 0.20(-205.3%) | 0.20(+233.3%) |
| Sep 2020 | - | 0.06(-66.7%) |
| Jun 2020 | - | 0.18(-18.2%) |
| Mar 2020 | - | 0.22(-215.8%) |
| Dec 2019 | -0.19(<-9900.0%) | -0.19(-51.3%) |
| Sep 2019 | - | -0.39(-38.1%) |
| Jun 2019 | - | -0.63(-106.7%) |
| Mar 2019 | - | 9.34(>+9900.0%) |
| Dec 2018 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2018 | - | 0.00(0.0%) |
| Jun 2018 | - | 0.00(0.0%) |
| Mar 2018 | - | 0.00(0.0%) |
| Dec 2017 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2017 | - | 0.00(0.0%) |
| Jun 2017 | - | 0.00(0.0%) |
| Mar 2017 | - | 0.00(0.0%) |
| Dec 2016 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2016 | - | 0.00(0.0%) |
| Jun 2016 | - | 0.00(0.0%) |
| Mar 2016 | - | 0.00(0.0%) |
| Dec 2015 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2015 | - | 0.00(0.0%) |
| Jun 2015 | - | 0.00(0.0%) |
| Mar 2015 | - | 0.00(0.0%) |
| Dec 2014 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2014 | - | 0.00(0.0%) |
| Jun 2014 | - | 0.00(0.0%) |
| Mar 2014 | - | 0.00(0.0%) |
| Dec 2013 | 0.00 | 0.00(0.0%) |
| Sep 2013 | - | 0.00(0.0%) |
| Jun 2013 | - | 0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | 0.00(0.0%) |
| Dec 2012 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2012 | - | 0.00(0.0%) |
| Jun 2012 | - | 0.00(0.0%) |
| Mar 2012 | - | 0.00(0.0%) |
| Dec 2011 | 0.00(-100.0%) | 0.00(0.0%) |
| Sep 2011 | - | 0.00(0.0%) |
| Jun 2011 | - | 0.00(0.0%) |
| Mar 2011 | - | 0.00(-100.0%) |
| Dec 2010 | -0.30(+42.9%) | -0.30(+328.6%) |
| Sep 2010 | - | -0.07(<-9900.0%) |
| Jun 2010 | - | 0.00(-100.0%) |
| Mar 2010 | - | 3.00(-1528.6%) |
| Dec 2009 | -0.21(0.0%) | -0.21(+110.0%) |
| Sep 2009 | - | -0.10(+11.1%) |
| Jun 2009 | - | -0.09(-50.0%) |
| Mar 2009 | - | -0.18(-14.3%) |
| Dec 2008 | -0.21(-66.7%) | -0.21(-19.2%) |
| Sep 2008 | - | -0.26(-3.7%) |
| Jun 2008 | - | -0.27(-52.6%) |
| Mar 2008 | - | -0.57(-9.5%) |
| Dec 2007 | -0.63(+1.6%) | -0.63(-11.3%) |
| Sep 2007 | - | -0.71(+16.4%) |
| Jun 2007 | - | -0.61(0.0%) |
| Mar 2007 | - | -0.61(-23.8%) |
| Dec 2006 | -0.62(+933.3%) | - |
| Sep 2006 | - | -0.80(-39.8%) |
| Jun 2006 | - | -1.33(+2116.7%) |
| Mar 2006 | - | -0.06(<-9900.0%) |
| Mar 2006 | -0.06(<-9900.0%) | - |
| Dec 2005 | - | 0.00(0.0%) |
| Sep 2005 | - | 0.00(0.0%) |
| Jun 2005 | - | 0.00(0.0%) |
| Mar 2005 | 0.00(0.0%) | 0.00(0.0%) |
| Dec 2004 | - | 0.00(0.0%) |
| Sep 2004 | - | 0.00(0.0%) |
| Jun 2004 | - | 0.00(0.0%) |
| Mar 2004 | 0.00(-100.0%) | 0.00(-100.0%) |
| Dec 2003 | - | 51.67(+716.3%) |
| Sep 2003 | - | 6.33(+268.0%) |
| Jun 2003 | - | 1.72(+67.0%) |
| Mar 2003 | 1.03(+442.1%) | 1.03(+45.1%) |
| Dec 2002 | - | 0.71(-22.0%) |
| Sep 2002 | - | 0.91(-2.2%) |
| Jun 2002 | - | 0.93 |
| Mar 2002 | 0.19 | - |
FAQ
- What is Brainstorm Cell Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics annual debt to equity year-on-year change?
- What is Brainstorm Cell Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics quarterly debt to equity year-on-year change?
What is Brainstorm Cell Therapeutics annual debt to equity ratio?
The current annual debt to equity of BCLI is -0.26
What is the all time high annual debt to equity for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high annual debt to equity ratio is 1.03
What is Brainstorm Cell Therapeutics annual debt to equity year-on-year change?
Over the past year, BCLI annual debt to equity ratio has changed by +1.10 (+80.88%)
What is Brainstorm Cell Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of BCLI is -0.14
What is the all time high quarterly debt to equity for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high quarterly debt to equity ratio is 51.67
What is Brainstorm Cell Therapeutics quarterly debt to equity year-on-year change?
Over the past year, BCLI quarterly debt to equity ratio has changed by +0.13 (+48.15%)